Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Farmers Insurance
McKesson
Teva
Fish and Richardson
Mallinckrodt
Medtronic
Chubb
Express Scripts

Generated: May 20, 2018

DrugPatentWatch Database Preview

SODIUM SUCCINATE Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Sodium Succinate patents expire, and what generic alternatives are available?

Sodium Succinate is a drug marketed by Elkins Sinn and is included in one NDA.

The generic ingredient in SODIUM SUCCINATE is sodium succinate. There are one thousand four hundred and twenty-six drug master file entries for this compound. Additional details are available on the sodium succinate profile page.
Summary for SODIUM SUCCINATE
Drug patent expirations by year for SODIUM SUCCINATE
Synonyms for SODIUM SUCCINATE
150-90-3
54296-EP2371811A2
AC1L1S54
AC1MC3R9
AC1Q1UQW
ACMC-1C1EP
AKOS015913971
AKOS015960584
AN-23318
anhydrous disodium succinate
anhydrous sodium succinate
Anhydrous Sodium Succinate, United States Pharmacopeia (USP) Reference Standard
Butanedioic acid disodium hexahydrate
Butanedioic acid disodium salt
Butanedioic acid, disodium salt
Butanedioic acid, sodium salt (1:2)
C4H4Na2O4
C4H4O4.2Na
CCRIS 3700
CHEBI:63675
CTK3J0993
D03RCJ
Disodium butanedioate
Disodium succinate
disodium succinate (anh.)
disodium succinate (anhydrous)
Disodium succinate, >=98%
Disodium Sulfosuccinate Decylglucoside Crosspolymer
Disodium Sulfosuccinate Laurylglucoside Crosspolymer
DTXSID5059741
EINECS 205-778-7
FEMA No. 3277
FT-0689142
I14-43632
J-008755
Jantaran sodny
Jantaran sodny [Czech]
Jsp002886
KS-000018XA
KSC490S9H
LS-147436
LS40932
MFCD00002789
MFCD00002790
MolPort-003-926-421
OR025159
OR224034
RL01926
RTR-006175
S0105
SCHEMBL24440
sodium succinate (anhydrous)
Sodium succinate anhydrous
Sodium succinate dibasic
Sodium succinate dibasic, purum, anhydrous, >=98.0% (NT)
Soduxin
Succinate, 0.2M buffer solution, pH 4.0
Succinate, 0.2M buffer solution, pH 4.5
Succinate, 0.2M buffer solution, pH 5.0
Succinate, 0.2M buffer solution, pH 5.5
Succinate, 0.2M buffer solution, pH 6.0
Succinate, 0.2M buffer solution, pH 6.5
Succinic acid disodium salt
Succinic acid disodium salt anhydrous
Succinic acid disodium salt, 99%
Succinic acid sodium
Succinic acid, disodium salt
Succinic acid,sodium salt
Succinicaciddisodiumsalt
TR-006175
TRA0031538
UNII-V8ZGC8ISR3
V1448
V8ZGC8ISR3
ZDQYSKICYIVCPN-UHFFFAOYSA-L

US Patents and Regulatory Information for SODIUM SUCCINATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Elkins Sinn SODIUM SUCCINATE sodium succinate INJECTABLE;INJECTION 080516-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
McKinsey
Cantor Fitzgerald
Citi
Medtronic
UBS
Chinese Patent Office
Farmers Insurance
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.